Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00120 | Muscular dystrophy-dystroglycanopathy type A | Muscular dystrophies due to reduced glycosylation of alpha-dystroglycan have emerged as a common group of conditions, now referred to as dystroglycanopathies. The phenotypic severity of dystroglycanopathy ... | Inherited metabolic disorder |
(MDDGA1) POMT1 [HSA:10585] [KO:K00728] (MDDGA2) POMT2 [HSA:29954] [KO:K00728] (MDDGA3) POMGNT1 [HSA:55624] [KO:K09666] (MDDGA4) FKTN [HSA:2218] [KO:K19872] (MDDGA5) FKRP [HSA:79147] [KO:K19873] (MDDGA6) LARGE [HSA:9215] [KO:K09668] (MDDGA7) CRPPA [HSA:729920] [KO:K21031] (MDDGA8) POMGNT2 [HSA:84892] [KO:K18207] (MDDGA9) DAG1 [HSA:1605] [KO:K06265] (MDDGA10) RXYLT1 [HSA:10329] [KO:K21052] (MDDGA11) B3GALNT2 [HSA:148789] [KO:K09654] (MDDGA12) POMK [HSA:84197] [KO:K17547] (MDDGA13) B4GAT1 [HSA:11041] [KO:K21032] (MDDGA14) GMPPB [HSA:29925] [KO:K00966] |
|
H02307 | Muscular dystrophy-dystroglycanopathy | Muscular dystrophies due to reduced glycosylation of alpha-dystroglycan have emerged as a common group of conditions, now referred to as dystroglycanopathies. The phenotypic severity of dystroglycanopathy ... | Inherited metabolic disorder |
POMT1 [HSA:10585] [KO:K00728] POMT2 [HSA:29954] [KO:K00728] POMGNT1 [HSA:55624] [KO:K09666] FKTN [HSA:2218] [KO:K19872] FKRP [HSA:79147] [KO:K19873] LARGE [HSA:9215] [KO:K09668] ISPD [HSA:729920] [KO:K21031] GTDC2 [HSA:84892] [KO:K18207] DAG1 [HSA:1605] [KO:K06265] TMEM5 [HSA:10329] [KO:K21052] B3GALNT2 [HSA:148789] [KO:K09654] POMK [HSA:84197] [KO:K17547] B3GNT1 [HSA:11041] [KO:K21032] GMPPB [HSA:29925] [KO:K00966] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |